Cargando…
Relationship between cervical esophageal squamous cell carcinoma and human papilloma virus infection and gene mutations
Cervical esophageal squamous cell carcinoma (CESCC) is rare, accounting for 5% of all esophageal carcinomas. Several diagnostic and predictive markers have been studied. However, to the best of our knowledge, no biomarker is known to determine patient management except the clinical stage. The presen...
Autores principales: | Fukahori, Masaru, Kato, Ken, Taniguchi, Hirokazu, Ohtomo, Rie, Takahashi, Naoki, Shoji, Hirokazu, Iwasa, Satoru, Honma, Yoshitaka, Takashima, Atsuo, Hamaguchi, Tetsuya, Yamada, Yasuhide, Shimada, Yasuhiro, Ito, Yoshinori, Itami, Jun, Hokamura, Nobukazu, Igaki, Hiroyasu, Tachimori, Yuji, Miwa, Keisuke, Torimura, Takuji, Boku, Narikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788557/ https://www.ncbi.nlm.nih.gov/pubmed/33437479 http://dx.doi.org/10.3892/mco.2020.2205 |
Ejemplares similares
-
Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer
por: Takahashi, Naoki, et al.
Publicado: (2014) -
Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503)
por: Iwasa, Satoru, et al.
Publicado: (2020) -
Esophageal Metastasis from Rectal Cancer Successfully Treated with Fluorouracil-Based Chemotherapy with Bevacizumab: A Case Report and Review of the Literature
por: Watanabe, Sho, et al.
Publicado: (2017) -
Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy
por: Tada, Kohei, et al.
Publicado: (2015) -
Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection
por: Shoji, Hirokazu, et al.
Publicado: (2014)